288eTiP A multicenter, open-label, first-in-human study of TYRA-430 in advanced hepatocellular carcinoma and other solid tumors with activating FGF/FGFR pathway aberrations (SURF431)Love Goyal, A. Zalutskaya, Alexander S. Vogel et al.|Annals of Oncology|2025Cited by 0